Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Postoperative Nausea and Vomiting Management Market Size Growth Rate by Type: 2018 VS 2022 VS 2033
1.2.2 Serotonin Antagonists
1.2.3 Steroids
1.2.4 Dopamine Antagonists
1.2.5 Neurokinin NK-1 Receptor Antagonists
1.2.6 Non-pharmacological Treatment
1.3 Market by Application
1.3.1 Global Postoperative Nausea and Vomiting Management Market Growth by Application: 2018 VS 2022 VS 2033
1.3.2 Hospital Pharmacies
1.3.3 Online Pharmacies
1.3.4 Retail Pharmacies and Drug Stores
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Postoperative Nausea and Vomiting Management Market Perspective (2018-2033)
2.2 Postoperative Nausea and Vomiting Management Growth Trends by Region
2.2.1 Global Postoperative Nausea and Vomiting Management Market Size by Region: 2018 VS 2022 VS 2033
2.2.2 Postoperative Nausea and Vomiting Management Historic Market Size by Region (2018-2023)
2.2.3 Postoperative Nausea and Vomiting Management Forecasted Market Size by Region (2024-2033)
2.3 Postoperative Nausea and Vomiting Management Market Dynamics
2.3.1 Postoperative Nausea and Vomiting Management Industry Trends
2.3.2 Postoperative Nausea and Vomiting Management Market Drivers
2.3.3 Postoperative Nausea and Vomiting Management Market Challenges
2.3.4 Postoperative Nausea and Vomiting Management Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Postoperative Nausea and Vomiting Management Players by Revenue
3.1.1 Global Top Postoperative Nausea and Vomiting Management Players by Revenue (2018-2023)
3.1.2 Global Postoperative Nausea and Vomiting Management Revenue Market Share by Players (2018-2023)
3.2 Global Postoperative Nausea and Vomiting Management Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Postoperative Nausea and Vomiting Management Revenue
3.4 Global Postoperative Nausea and Vomiting Management Market Concentration Ratio
3.4.1 Global Postoperative Nausea and Vomiting Management Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Postoperative Nausea and Vomiting Management Revenue in 2022
3.5 Postoperative Nausea and Vomiting Management Key Players Head office and Area Served
3.6 Key Players Postoperative Nausea and Vomiting Management Product Solution and Service
3.7 Date of Enter into Postoperative Nausea and Vomiting Management Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Postoperative Nausea and Vomiting Management Breakdown Data by Type
4.1 Global Postoperative Nausea and Vomiting Management Historic Market Size by Type (2018-2023)
4.2 Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Type (2024-2033)
5 Postoperative Nausea and Vomiting Management Breakdown Data by Application
5.1 Global Postoperative Nausea and Vomiting Management Historic Market Size by Application (2018-2023)
5.2 Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Application (2024-2033)
6 North America
6.1 North America Postoperative Nausea and Vomiting Management Market Size (2018-2033)
6.2 North America Postoperative Nausea and Vomiting Management Market Growth Rate by Country: 2018 VS 2022 VS 2033
6.3 North America Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023)
6.4 North America Postoperative Nausea and Vomiting Management Market Size by Country (2024-2033)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Postoperative Nausea and Vomiting Management Market Size (2018-2033)
7.2 Europe Postoperative Nausea and Vomiting Management Market Growth Rate by Country: 2018 VS 2022 VS 2033
7.3 Europe Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023)
7.4 Europe Postoperative Nausea and Vomiting Management Market Size by Country (2024-2033)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size (2018-2033)
8.2 Asia-Pacific Postoperative Nausea and Vomiting Management Market Growth Rate by Region: 2018 VS 2022 VS 2033
8.3 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region (2018-2023)
8.4 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region (2024-2033)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Postoperative Nausea and Vomiting Management Market Size (2018-2033)
9.2 Latin America Postoperative Nausea and Vomiting Management Market Growth Rate by Country: 2018 VS 2022 VS 2033
9.3 Latin America Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023)
9.4 Latin America Postoperative Nausea and Vomiting Management Market Size by Country (2024-2033)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Postoperative Nausea and Vomiting Management Market Size (2018-2033)
10.2 Middle East & Africa Postoperative Nausea and Vomiting Management Market Growth Rate by Country: 2018 VS 2022 VS 2033
10.3 Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023)
10.4 Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country (2024-2033)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Acacia Pharma
11.1.1 Acacia Pharma Company Detail
11.1.2 Acacia Pharma Business Overview
11.1.3 Acacia Pharma Postoperative Nausea and Vomiting Management Introduction
11.1.4 Acacia Pharma Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.1.5 Acacia Pharma Recent Development
11.2 Roche
11.2.1 Roche Company Detail
11.2.2 Roche Business Overview
11.2.3 Roche Postoperative Nausea and Vomiting Management Introduction
11.2.4 Roche Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.2.5 Roche Recent Development
11.3 Novartis AG
11.3.1 Novartis AG Company Detail
11.3.2 Novartis AG Business Overview
11.3.3 Novartis AG Postoperative Nausea and Vomiting Management Introduction
11.3.4 Novartis AG Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.3.5 Novartis AG Recent Development
11.4 Ani Pharmaceuticals, Inc
11.4.1 Ani Pharmaceuticals, Inc Company Detail
11.4.2 Ani Pharmaceuticals, Inc Business Overview
11.4.3 Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Introduction
11.4.4 Ani Pharmaceuticals, Inc Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.4.5 Ani Pharmaceuticals, Inc Recent Development
11.5 Camurus AB
11.5.1 Camurus AB Company Detail
11.5.2 Camurus AB Business Overview
11.5.3 Camurus AB Postoperative Nausea and Vomiting Management Introduction
11.5.4 Camurus AB Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.5.5 Camurus AB Recent Development
11.6 Sanofi S.A.
11.6.1 Sanofi S.A. Company Detail
11.6.2 Sanofi S.A. Business Overview
11.6.3 Sanofi S.A. Postoperative Nausea and Vomiting Management Introduction
11.6.4 Sanofi S.A. Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.6.5 Sanofi S.A. Recent Development
11.7 Helsinn Holding S.A.
11.7.1 Helsinn Holding S.A. Company Detail
11.7.2 Helsinn Holding S.A. Business Overview
11.7.3 Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Introduction
11.7.4 Helsinn Holding S.A. Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.7.5 Helsinn Holding S.A. Recent Development
11.8 Eisai Corporation
11.8.1 Eisai Corporation Company Detail
11.8.2 Eisai Corporation Business Overview
11.8.3 Eisai Corporation Postoperative Nausea and Vomiting Management Introduction
11.8.4 Eisai Corporation Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.8.5 Eisai Corporation Recent Development
11.9 Merck and Co.
11.9.1 Merck and Co. Company Detail
11.9.2 Merck and Co. Business Overview
11.9.3 Merck and Co. Postoperative Nausea and Vomiting Management Introduction
11.9.4 Merck and Co. Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.9.5 Merck and Co. Recent Development
11.10 GlaxoSmithKline
11.10.1 GlaxoSmithKline Company Detail
11.10.2 GlaxoSmithKline Business Overview
11.10.3 GlaxoSmithKline Postoperative Nausea and Vomiting Management Introduction
11.10.4 GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023)
11.10.5 GlaxoSmithKline Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Postoperative Nausea and Vomiting Management Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2033
Table 2. Key Players of Serotonin Antagonists
Table 3. Key Players of Steroids
Table 4. Key Players of Dopamine Antagonists
Table 5. Key Players of Neurokinin NK-1 Receptor Antagonists
Table 6. Key Players of Non-pharmacological Treatment
Table 7. Global Postoperative Nausea and Vomiting Management Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2033
Table 8. Global Postoperative Nausea and Vomiting Management Market Size by Region (US$ Million): 2018 VS 2022 VS 2033
Table 9. Global Postoperative Nausea and Vomiting Management Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Postoperative Nausea and Vomiting Management Market Share by Region (2018-2023)
Table 11. Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 12. Global Postoperative Nausea and Vomiting Management Market Share by Region (2024-2033)
Table 13. Postoperative Nausea and Vomiting Management Market Trends
Table 14. Postoperative Nausea and Vomiting Management Market Drivers
Table 15. Postoperative Nausea and Vomiting Management Market Challenges
Table 16. Postoperative Nausea and Vomiting Management Market Restraints
Table 17. Global Postoperative Nausea and Vomiting Management Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Postoperative Nausea and Vomiting Management Market Share by Players (2018-2023)
Table 19. Global Top Postoperative Nausea and Vomiting Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting Management as of 2022)
Table 20. Ranking of Global Top Postoperative Nausea and Vomiting Management Companies by Revenue (US$ Million) in 2022
Table 21. Global 5 Largest Players Market Share by Postoperative Nausea and Vomiting Management Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Postoperative Nausea and Vomiting Management Product Solution and Service
Table 24. Date of Enter into Postoperative Nausea and Vomiting Management Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Postoperative Nausea and Vomiting Management Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Postoperative Nausea and Vomiting Management Revenue Market Share by Type (2018-2023)
Table 28. Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 29. Global Postoperative Nausea and Vomiting Management Revenue Market Share by Type (2024-2033)
Table 30. Global Postoperative Nausea and Vomiting Management Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Postoperative Nausea and Vomiting Management Revenue Market Share by Application (2018-2023)
Table 32. Global Postoperative Nausea and Vomiting Management Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 33. Global Postoperative Nausea and Vomiting Management Revenue Market Share by Application (2024-2033)
Table 34. North America Postoperative Nausea and Vomiting Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 35. North America Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Postoperative Nausea and Vomiting Management Market Size by Country (2024-2033) & (US$ Million)
Table 37. Europe Postoperative Nausea and Vomiting Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 38. Europe Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Postoperative Nausea and Vomiting Management Market Size by Country (2024-2033) & (US$ Million)
Table 40. Asia-Pacific Postoperative Nausea and Vomiting Management Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2033
Table 41. Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region (2024-2033) & (US$ Million)
Table 43. Latin America Postoperative Nausea and Vomiting Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 44. Latin America Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Postoperative Nausea and Vomiting Management Market Size by Country (2024-2033) & (US$ Million)
Table 46. Middle East & Africa Postoperative Nausea and Vomiting Management Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2033
Table 47. Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country (2024-2033) & (US$ Million)
Table 49. Acacia Pharma Company Detail
Table 50. Acacia Pharma Business Overview
Table 51. Acacia Pharma Postoperative Nausea and Vomiting Management Product
Table 52. Acacia Pharma Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023) & (US$ Million)
Table 53. Acacia Pharma Recent Development
Table 54. Roche Company Detail
Table 55. Roche Business Overview
Table 56. Roche Postoperative Nausea and Vomiting Management Product
Table 57. Roche Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023) & (US$ Million)
Table 58. Roche Recent Development
Table 59. Novartis AG Company Detail
Table 60. Novartis AG Business Overview
Table 61. Novartis AG Postoperative Nausea and Vomiting Management Product
Table 62. Novartis AG Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023) & (US$ Million)
Table 63. Novartis AG Recent Development
Table 64. Ani Pharmaceuticals, Inc Company Detail
Table 65. Ani Pharmaceuticals, Inc Business Overview
Table 66. Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Product
Table 67. Ani Pharmaceuticals, Inc Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023) & (US$ Million)
Table 68. Ani Pharmaceuticals, Inc Recent Development
Table 69. Camurus AB Company Detail
Table 70. Camurus AB Business Overview
Table 71. Camurus AB Postoperative Nausea and Vomiting Management Product
Table 72. Camurus AB Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023) & (US$ Million)
Table 73. Camurus AB Recent Development
Table 74. Sanofi S.A. Company Detail
Table 75. Sanofi S.A. Business Overview
Table 76. Sanofi S.A. Postoperative Nausea and Vomiting Management Product
Table 77. Sanofi S.A. Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023) & (US$ Million)
Table 78. Sanofi S.A. Recent Development
Table 79. Helsinn Holding S.A. Company Detail
Table 80. Helsinn Holding S.A. Business Overview
Table 81. Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Product
Table 82. Helsinn Holding S.A. Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023) & (US$ Million)
Table 83. Helsinn Holding S.A. Recent Development
Table 84. Eisai Corporation Company Detail
Table 85. Eisai Corporation Business Overview
Table 86. Eisai Corporation Postoperative Nausea and Vomiting Management Product
Table 87. Eisai Corporation Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023) & (US$ Million)
Table 88. Eisai Corporation Recent Development
Table 89. Merck and Co. Company Detail
Table 90. Merck and Co. Business Overview
Table 91. Merck and Co. Postoperative Nausea and Vomiting Management Product
Table 92. Merck and Co. Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023) & (US$ Million)
Table 93. Merck and Co. Recent Development
Table 94. GlaxoSmithKline Company Detail
Table 95. GlaxoSmithKline Business Overview
Table 96. GlaxoSmithKline Postoperative Nausea and Vomiting Management Product
Table 97. GlaxoSmithKline Revenue in Postoperative Nausea and Vomiting Management Business (2018-2023) & (US$ Million)
Table 98. GlaxoSmithKline Recent Development
Table 99. Research Programs/Design for This Report
Table 100. Key Data Information from Secondary Sources
Table 101. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Postoperative Nausea and Vomiting Management Market Size Comparison by Type (2023-2033) & (US$ Million)
Figure 2. Global Postoperative Nausea and Vomiting Management Market Share by Type: 2022 VS 2033
Figure 3. Serotonin Antagonists Features
Figure 4. Steroids Features
Figure 5. Dopamine Antagonists Features
Figure 6. Neurokinin NK-1 Receptor Antagonists Features
Figure 7. Non-pharmacological Treatment Features
Figure 8. Global Postoperative Nausea and Vomiting Management Market Size Comparison by Application (2023-2033) & (US$ Million)
Figure 9. Global Postoperative Nausea and Vomiting Management Market Share by Application: 2022 VS 2033
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Online Pharmacies Case Studies
Figure 12. Retail Pharmacies and Drug Stores Case Studies
Figure 13. Postoperative Nausea and Vomiting Management Report Years Considered
Figure 14. Global Postoperative Nausea and Vomiting Management Market Size (US$ Million), Year-over-Year: 2018-2033
Figure 15. Global Postoperative Nausea and Vomiting Management Market Size, (US$ Million), 2018 VS 2022 VS 2033
Figure 16. Global Postoperative Nausea and Vomiting Management Market Share by Region: 2022 VS 2033
Figure 17. Global Postoperative Nausea and Vomiting Management Market Share by Players in 2022
Figure 18. Global Top Postoperative Nausea and Vomiting Management Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Postoperative Nausea and Vomiting Management as of 2022)
Figure 19. The Top 10 and 5 Players Market Share by Postoperative Nausea and Vomiting Management Revenue in 2022
Figure 20. North America Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 21. North America Postoperative Nausea and Vomiting Management Market Share by Country (2018-2033)
Figure 22. United States Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 23. Canada Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 24. Europe Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 25. Europe Postoperative Nausea and Vomiting Management Market Share by Country (2018-2033)
Figure 26. Germany Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 27. France Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 28. U.K. Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 29. Italy Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 30. Russia Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 31. Nordic Countries Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 32. Asia-Pacific Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 33. Asia-Pacific Postoperative Nausea and Vomiting Management Market Share by Region (2018-2033)
Figure 34. China Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 35. Japan Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 36. South Korea Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 37. Southeast Asia Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 38. India Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 39. Australia Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 40. Latin America Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 41. Latin America Postoperative Nausea and Vomiting Management Market Share by Country (2018-2033)
Figure 42. Mexico Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 43. Brazil Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 44. Middle East & Africa Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 45. Middle East & Africa Postoperative Nausea and Vomiting Management Market Share by Country (2018-2033)
Figure 46. Turkey Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 47. Saudi Arabia Postoperative Nausea and Vomiting Management Market Size YoY Growth (2018-2033) & (US$ Million)
Figure 48. Acacia Pharma Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2018-2023)
Figure 49. Roche Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2018-2023)
Figure 50. Novartis AG Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2018-2023)
Figure 51. Ani Pharmaceuticals, Inc Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2018-2023)
Figure 52. Camurus AB Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2018-2023)
Figure 53. Sanofi S.A. Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2018-2023)
Figure 54. Helsinn Holding S.A. Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2018-2023)
Figure 55. Eisai Corporation Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2018-2023)
Figure 56. Merck and Co. Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2018-2023)
Figure 57. GlaxoSmithKline Revenue Growth Rate in Postoperative Nausea and Vomiting Management Business (2018-2023)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed